Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.

- www.clinicaltrials.gov Once you are on the website, type "NCT04480879"
into the search box and click "Search".

- www.clinicaltrialsregister.eu Once you are on the website, click "Home and Search",
then type "2019-004331-23" in the search box and click "Search".

- www.AstraZenecaClinicalTrials.com Once you are on the website, type "D8900C00005"
into the search box, and click "Find a Study".

Full Study Title: A Randomised, 3-Period, Single-dose, Open-label Crossover Study to Evaluate
the Systemic Exposure of AZD8154 While Administered via Inhalation Using a Nebuliser
Formulation and a Monodose Dry Powder Inhaler (DPI) Formulation in Healthy Subjects

AstraZeneca AB Protocol Number: D8900C00005
National Clinical Trials Number: NCT04480879
EudraCT Number: 2019-004331-23

AstraZeneca AB sponsored this study and has its headquarters at Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.

Thank you

Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health questions
and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.

CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2021_10_28